Nuvalent (NUVL) Other Operating Expenses (2022 - 2025)
Nuvalent (NUVL) posted Other Operating Expenses of -$101.2 million for Q3 2025, up 61.49% on a QoQ basis from -$262.9 million in Q4 2024, and down 41.07% year-over-year from -$171.8 million in Q3 2024.
Nuvalent (NUVL) Other Operating Expenses (2022 - 2025) Analysis & Trends
Nuvalent's Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$101.2 million for Q3 2025.
- Quarterly Other Operating Expenses fell 41.07% year-over-year to -$101.2 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$101.2 million (up 69.75% YoY) and the FY2024 annual result came in at -$262.9 million, down 87.49% from the prior year.
- Other Operating Expenses was -$101.2 million for Q3 2025 at Nuvalent, up from -$262.9 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at -$71.8 million in Q3 2024 and bottomed at -$262.9 million in Q4 2024.
- A 4-year average of -$131.0 million and a median of -$101.2 million in 2025 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses tumbled 87.49% — and 2025, when it slumped 41.07%.
- Nuvalent's Other Operating Expenses stood at -$79.0 million in 2022, then tumbled by 77.5% to -$140.2 million in 2023, then tumbled by 87.49% to -$262.9 million in 2024, then soared by 61.49% to -$101.2 million in 2025.
- Business Quant data shows NUVL's Other Operating Expenses at -$101.2 million in Q3 2025, -$262.9 million in Q4 2024, and -$71.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -101.24 Mn |
| Dec 31, 2024 | -262.86 Mn |
| Sep 30, 2024 | -71.76 Mn |
| Dec 31, 2023 | -140.20 Mn |
| Dec 31, 2022 | -78.99 Mn |